Renu Singh, PhD, MS

Gilead Sciences, Inc.

Disclosure(s): Aspire Scientific: Medical writing support; Gilead Sciences, Inc.: 1475-US-PSP, 1475-WO-PCT, 1474-US-PSP, 1515-US-PSP, 1515-WO-PCT, Medical writing support and Employee, Stocks/Bonds (Public Company)

Poster(s):

• (P-299) No Clinically Significant Drug-Drug Interactions Between Lenacapavir and Hormonal Contraceptives in PURPOSE 1
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-305) No Clinically Significant Drug–Drug Interactions with Co-administration of Feminizing or Masculinizing Hormone Therapy and Twice-yearly Lenacapavir PrEP in Gender-Diverse Persons
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET